Americans face challenges accessing weight-loss drugs due to shortages, costs, and insurance issues.

Americans are facing challenges accessing weight-loss drugs like Mounjaro and Wegovy due to supply shortages, insurance issues, and high costs. These obstacles have led some to seek cheaper, compounded versions online, raising concerns about safety and effectiveness. Drugmakers Eli Lilly and Novo Nordisk reported significant sales shortfalls for their obesity drugs. Although the FDA has addressed some supply issues, patients still struggle to fill prescriptions.

November 04, 2024
22 Articles